Repolar Pharmaceuticals Ltd is a family firm founded in 2006. The company researches, develops, produces and markets preparations for the treatment of wound, skin and nail bacterial and fungal inflammations, the effectiveness of which stems from the properties of components refined from the resin of the Finnish forest spruce (Picea abies). The headquarter of the Repolar Pharmaceuticals Ltd is located in Espoo and the company has production facilities in Kolari, Lapland. The company is a member of the Finnish Family Firms Association.